Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 3/20 | 0.50 |
| ▸ | KCNN4 | O15554 | 4/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | IDO1 | P14902 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA5A | P35218 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | AGXT | P21549 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL7233523 | 0.97 | KIF11 (0.48) | KIF11KCNN4MAPK1TSHRALDH1A1 | |
| SCHEMBL14619311 | 0.86 | KIF11 (0.50) | KIF11KCNN4MAPK1TSHRKMT2A | |
| SCHEMBL21738735 | 0.82 | KIF11 (0.56) | KIF11MAPK1CA1CA2CA9 | |
| SCHEMBL8728589 | 0.82 | KIF11 (0.56) | KIF11MAPK1CA1CA2CA9 | |
| SCHEMBL4755700 | 0.78 | KCNN4 (0.57) | KIF11KCNN4MAPK1TSHRALOX15 | |
| SCHEMBL297786 | 0.75 | MAPK1 (0.52) | KIF11KCNN4MAPK1TSHRALDH1A1 | |
| SCHEMBL8973 | 0.75 | KIF11 (0.48) | KIF11KCNN4MAPK1TSHRALDH1A1 | |
| SCHEMBL3861253 | 0.75 | KIF11 (0.36) | KIF11KCNN4ALOX15 | |
| SCHEMBL10622807 | 0.74 | KCNN4 (0.52) | KIF11KCNN4MAPK1TSHRALDH1A1 | |
| SCHEMBL5050649 | 0.73 | KCNN4 (0.35) | KIF11KCNN4MAPK1ALDH1A1TAAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 297 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260069712-A1 | METHODS FOR PURIFICATION OF IONIZABLE LIPIDS | MODERNATX, INC. (US) | 2026-03-12 | — | — | US | claimed |
| EP-4577519-A1 | METHODS FOR PURIFICATION OF IONIZABLE LIPIDS | ModernaTX, Inc. (US) | 2025-07-02 | — | — | EP | claimed |
| WO-2024044147-A1 | METHODS FOR PURIFICATION OF IONIZABLE LIPIDS | MODERNATX, INC. (US) | 2024-02-29 | — | — | WO | claimed |
| CN-115950970-A | HPLC detection method for ketose in aldose | 唐传生物科技（厦门）有限公司 | 2023-04-11 | — | — | CN | claimed |
| CN-115932076-A | Method for detecting ketose in aldose | 唐传生物科技（厦门）有限公司 | 2023-04-07 | — | — | CN | claimed |
| CN-111747957-B | Multi-target antitumor quinolizidine derivatives, and preparation method and application thereof | 天津市医药科学研究所 | 2022-12-09 | — | — | CN | claimed |
| CN-111747957-A | Multi-target antitumor quinolizidine derivatives, and preparation method and application thereof | 天津市医药科学研究所 | 2020-10-09 | — | — | CN | claimed |
| US-20090233307-A1 | METHODS FOR DETECTION OF SINGLE STRAND BREAKS IN DNA | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | 2009-09-17 | — | — | US | claimed |
| EP-4039257-B1 | PHARMACEUTICAL COMPOSITION AND KIT CONTAINING A PENAM DERIVATIVE OR SALT THEREOF AND ONE OR MORE COMPOUNDS SELECTED FROM BETA-LACTAMASE INHIBITOR COMPOUND, ANTIBACTERIAL COMPOUND AND SALTS OF THESE | FUJIFILM CORP (JP) | 2026-05-27 | — | — | EP | disclosed |
| US-12617813-B2 | Glycosylated histone deacetylase inhibitors and methods of making and using the same | GEORGIA TECH RESEARCH CORPORATION (US) | 2026-05-05 | — | — | US | disclosed |
| US-20260069712-A1 | METHODS FOR PURIFICATION OF IONIZABLE LIPIDS | MODERNATX, INC. (US) | 2026-03-12 | — | — | US | disclosed |
| CN-121574071-A | Binary hydroxamic acid compound, rare earth metal organic framework material, and preparation methods and applications thereof | 浙江大学衢州研究院 | 2026-02-27 | — | — | CN | disclosed |
| US-20260027227-A1 | NOVEL THIOL REDUCTANT, METHOD AND USE THEREOF | SUZHOU BIOREINNO BIOTECHNOLOGY LTD COMPANY (CN) | 2026-01-29 | — | — | US | disclosed |
| US-20250326775-A1 | A NOVEL THIOL REDUCTANT, PREPARATION METHOD AND USE THEREOF | SUZHOU BIOREINNO BIOTECHNOLOGY LTD COMPANY (CN) | 2025-10-23 | — | — | US | disclosed |
| EP-0133534-B1 | PYRIDYL COMPOUNDS | THE WELLCOME FOUNDATION LIMITED (GB) | 1990-10-10 | — | — | EP | disclosed |
| US-4690933-A | Pyridylvinyl-1H tetrazole having antihistamine activity | BURROUGHS WELLCOME CO. (US) | 1987-09-01 | — | — | US | disclosed |
| US-4574153-A | 8-Oxo-2-oxa-1-azabicyclo(4.2.0)octane-3-carboxylic acids | E. R. SQUIBB & SONS, INC. (US) | 1986-03-04 | — | — | US | disclosed |
| EP-0133534-A2 | Pyridyl compounds | THE WELLCOME FOUNDATION LIMITED (GB) | 1985-02-27 | — | — | EP | disclosed |
| US-4411898-A | CEPHALOSPORIN ANTIBACTERIAL AGENTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1983-10-25 | — | — | US | disclosed |
| US-4288436-A | ANTIBIOTICS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1981-09-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12617813-B2 | Glycosylated histone deacetylase inhibitors and methods of making and using the same | HDAC3, HDAC1, HDAC11 | KIF11 3408/4885KCNN4 4663/4885MAPK1 1840/4885 |
| US-20260027227-A1 | NOVEL THIOL REDUCTANT, METHOD AND USE THEREOF | CBR1, SCLY, SSB | KIF11 4192/4885KCNN4 1078/4885MAPK1 2996/4885 |
| US-20250326775-A1 | A NOVEL THIOL REDUCTANT, PREPARATION METHOD AND USE THEREOF | TMT1A, TST, PRDX3 | KIF11 2446/4885KCNN4 4679/4885MAPK1 4159/4885 |
| US-20260069712-A1 | METHODS FOR PURIFICATION OF IONIZABLE LIPIDS | ADAR, HNRNPL, APOL1 | KIF11 1499/4885KCNN4 1154/4885MAPK1 4249/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.